The median number of leiomyomas was 2 (range 1–16), the median number of MED12-mutation-positive tumours was 2 (range 0–16), and the median number of mutation-negative tumours was 1 (range 0–5) per patient. This evidence concerns the gene MED12 and neoplasm.